Occudo Quantitative Strategies LP acquired a new stake in Amdocs Limited (NASDAQ:DOX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 4,628 shares of the technology company’s stock, valued at approximately $394,000.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Amdocs by 11.6% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 55,076 shares of the technology company’s stock valued at $4,689,000 after purchasing an additional 5,713 shares in the last quarter. MJP Associates Inc. ADV acquired a new position in Amdocs in the fourth quarter valued at approximately $527,000. Lazard Asset Management LLC boosted its holdings in Amdocs by 30.9% in the fourth quarter. Lazard Asset Management LLC now owns 12,812 shares of the technology company’s stock valued at $1,090,000 after purchasing an additional 3,023 shares in the last quarter. Jefferies Financial Group Inc. acquired a new position in Amdocs in the fourth quarter valued at approximately $1,646,000. Finally, Ethic Inc. boosted its holdings in Amdocs by 54.0% in the fourth quarter. Ethic Inc. now owns 12,739 shares of the technology company’s stock valued at $1,085,000 after purchasing an additional 4,466 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.
Amdocs Price Performance
DOX stock opened at $90.68 on Friday. The company has a market capitalization of $10.24 billion, a P/E ratio of 21.04, a PEG ratio of 1.47 and a beta of 0.51. Amdocs Limited has a twelve month low of $74.41 and a twelve month high of $94.61. The business has a 50 day simple moving average of $87.49 and a 200-day simple moving average of $87.08. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22.
Amdocs Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.32%. The ex-dividend date of this dividend is Monday, June 30th. Amdocs’s dividend payout ratio (DPR) is presently 44.21%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, February 28th.
View Our Latest Analysis on DOX
About Amdocs
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Recommended Stories
- Five stocks we like better than Amdocs
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Walmart Stock Alert: Big Price Move Expected Soon
- Most active stocks: Dollar volume vs share volume
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Growth Stocks: What They Are, What They Are Not
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.